TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,810,776 | -48.8% | 216,600 | +52.0% | 2.08% | -55.6% |
| Q2 2023 | $3,539,700 | -30.7% | 142,500 | -58.0% | 4.68% | -19.0% |
| Q1 2023 | $5,106,080 | +313.4% | 339,500 | +225.2% | 5.77% | +390.5% |
| Q4 2022 | $1,235,052 | -38.4% | 104,400 | -69.2% | 1.18% | -43.8% |
| Q3 2022 | $2,006,000 | -35.0% | 338,800 | -53.3% | 2.09% | -39.5% |
| Q2 2022 | $3,086,000 | -69.0% | 726,200 | -30.7% | 3.46% | -62.3% |
| Q1 2022 | $9,966,000 | -0.5% | 1,047,900 | +98.8% | 9.16% | +17.2% |
| Q4 2021 | $10,013,000 | – | 527,000 | – | 7.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |